D. Symmons

发表

Methodological issues when measuring paid productivity loss in patients with arthritis using biologic therapies: an overview of the literature.

A. Boonen, S. Dadoun, B. Fautrel, 2012, Rheumatology.

Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?

D. Scott, D. Symmons, Linda Mary Davies, 2006, Annals of the rheumatic diseases.

Total costs and predictors of costs in individuals with early inflammatory polyarthritis: a community-based prospective study.

N J Cooper, M. Mugford, E. Barrett, 2002, Rheumatology.

Consultant rheumatology workforce in the UK: changing patterns of provision 1997-2001.

G. Turner, D. Symmons, A. Bamji, 2002, Rheumatology.

Has the Severity of Rheumatoid Arthritis at Presentation Diminished Over Time?

M. Lunt, J. Chipping, T. Marshall, 2014, The Journal of Rheumatology.

Health Assessment Questionnaire disability progression in early rheumatoid arthritis: Systematic review and analysis of two inception cohorts

Mark Lunt, Sam Norton, Bo Fu, 2014, Seminars in arthritis and rheumatism.

Not all moderate disease is the same – Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity

S. Norton, M. Lunt, A. Young, 2019, PloS one.

BSPAR ANNUAL CONFERENCE ABSTRACTS (presented in alphabetical order of first author)

C. May, A. Dick, K. Mandal, 2011 .

Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries

K. Michaud, J. Greenberg, D. Pappas, 2015, Arthritis care & research.

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme

K. Michaud, J. Greenberg, D. Pappas, 2017, RMD Open.

Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease

K. Michaud, J. Greenberg, D. Pappas, 2016, Annals of the rheumatic diseases.

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis

N. Bansback, L. Davies, S. Verstappen, 2009, Quality of Life Research.

The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review.

N. Bansback, A. Anis, L. Davies, 2008, The Journal of rheumatology.

Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data

Ehrenstein, I. Bruce, Jane Worthington, 2018, RMD Open.

Development of resource-use and expenditure questionnaires for use in rheumatology research.

M. Mugford, E. Barrett, D. Scott, 2003, The Journal of rheumatology.

M. Lunt, S. Verstappen, D. Symmons, 2017, Arthritis & rheumatology.

Response to: Immortal Time Bias: Comment on the Article by Gwinnutt et al

M. Lunt, S. Verstappen, D. Symmons, 2017 .

How Do We Classify Rheumatoid Arthritis in Established Disease — Can We Apply the 2010 American College of Rheumatology/European League Against Rheumatism Classification Criteria?

J. Humphreys, T. Uhlig, T. Sokka, 2014, The Journal of Rheumatology.

Learned helplessness predicts functional disability, pain and fatigue in patients with recent-onset inflammatory polyarthritis

J. Chipping, S. Verstappen, D. Symmons, 2013, Rheumatology.

Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach

Trung Nghia Tran, K. Michaud, J. Greenberg, 2015, Pharmacoepidemiology and drug safety.

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Francisco Bonachela Capdevila, I. Bruce, Jane Worthington, 2022, Scientific Data.

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.

K. Michaud, J. Greenberg, D. Pappas, 2016, Annals of the rheumatic diseases.

Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study

S. Hider, M. Lee, N. Viner, 2022, Rheumatology.

Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.

A. Brennan, N. Bansback, J. Madan, 2007, Rheumatology.

Association of HLA-DRB 1 HaplotypesWith Rheumatoid Arthritis Severity , Mortality , and Treatment Response

A. Barton, S. Raychaudhuri, J. Isaacs, 2015 .

Identifying and managing psoriasis-associated comorbidities: the IMPACT research programme

M. Rutter, C. Chew‐Graham, K. Lovell, 2022, Programme Grants for Applied Research.

Long-term persistence with rituximab in patients with rheumatoid arthritis

J. Sergeant, M. Lunt, K. Hyrich, 2018, Rheumatology.

The British Society for Rheumatology Biologics Register. Ann Rheum Dis 2005;64 Suppl 4:iv42–3

A. Silman, W. Dixon, D. Symmons, 2022 .

Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation

Michelle Urwin, Deborah Symmons, Timothy Allison, 1998, Annals of the rheumatic diseases.

Developments in rheumatology consultant manpower provision: the BSR/arc Workforce Register 2003-05.

D. Symmons, M. Harrison, K. Morley, 2006, Rheumatology.

Influence of age and sex on functional outcome over time in a cohort of patients with recent‐onset inflammatory polyarthritis: Results from the Norfolk arthritis register

M. Lunt, D. Bunn, S. Verstappen, 2011, Arthritis care & research.

What is the outcome of RA in 2011 and can we predict it?

S. Verstappen, D. Symmons, 2011, Best practice & research. Clinical rheumatology.

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Mark Lunt, William G Dixon, W. Dixon, 2017, Annals of the rheumatic diseases.

Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink.

Mark Lunt, Rosa Parisi, M. Rutter, 2015, The Journal of investigative dermatology.

Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register

M. Lunt, A. Macgregor, J. Chipping, 2018, Annals of the rheumatic diseases.

Twenty‐Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register

M. Lunt, A. Macgregor, J. Chipping, 2017, Arthritis & rheumatology.

Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register

M. Lunt, C. Scirè, T. Marshall, 2013, Annals of the rheumatic diseases.

Editorial: Do We Need a Disease‐Specific Cardiovascular Risk Calculator for Patients With Rheumatoid Arthritis?

D. Symmons, 2015, Arthritis & rheumatology.

Baseline patient reported outcomes are more consistent predictors of long-term functional disability than laboratory, imaging or joint count data in patients with early inflammatory arthritis: A systematic review

M. Lunt, S. Verstappen, D. Symmons, 2018, Seminars in arthritis and rheumatism.

The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis Seminars in Arthritis and Rheumatism

M. Hotopf, G. Kingsley, S. Steer, 2014 .

CHAPTER 1 – Classification Criteria

Deborah P. M. Symmons, Hoda Mirjafari, D. Symmons, 2009 .

Predictors of and outcomes following orthopaedic joint surgery in patients with early rheumatoid arthritis followed for 20 years

M. Lunt, A. Macgregor, J. Chipping, 2017, Rheumatology.

An update on UK rheumatology consultant workforce provision: the BSR/ARC Workforce Register 2005–07: assessing the impact of recent changes in NHS provision

C. Deighton, D. Symmons, M. Harrison, 2008, Rheumatology.

Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials

Claire M. Riddell, R. Moots, D. Symmons, 2019, The Lancet Rheumatology.

Epidemiologic concepts and the classification of musculoskeletal conditions

D. Symmons, 2011 .

A Threshold Hazard Model for Estimating Serious Infection Risk Following Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients

Mark Lunt, Bo Fu, Kimme Hyrich, 2013, Journal of biopharmaceutical statistics.

Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.

N. Bansback, T. Farragher, L. Davies, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate.

A. Barton, S. Hider, M. Lee, 2019, Rheumatology.

Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect Modification

Mark Lunt, Til Stürmer, Daniel Solomon, 2009, American journal of epidemiology.

Is the relationship between deprivation and outcomes in rheumatoid arthritis mediated by body mass index? A longitudinal cohort study

S. Hider, M. Lee, N. Viner, 2022, Rheumatology.

Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis

W. Thomson, M. Lunt, D. Ashcroft, 2008, Rheumatology.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

W. Dixon, M. Lunt, A. Ustianowski, 2009, Annals of the rheumatic diseases.

Why Do Patients with Inflammatory Arthritis Often Score States “ Worse than Death ” on the EQ-5 D ? An Investigation of the EQ-5 D Classification

N. Bansback, T. Farragher, L. Davies, 2009 .

153. ASSESSMENT OF PREDICTORS OF AND OUTCOMES FOLLOWING ORTHOPAEDIC JOINT SURGERY OVER 20 YEARS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS RECRUITED TO THE NORFOLK ARTHRITIS REGISTER

M. Lunt, A. Macgregor, J. Chipping, 2017 .

Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s

N. Goodson, M. Lunt, D. Symmons, 2005, Annals of the rheumatic diseases.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

D. Symmons, L. Hooper, K. Payne, 2006, Health technology assessment.

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

K. Hyrich, S. Verstappen, D. Symmons, 2011 .

Mortality Trends in Patients With Early Rheumatoid Arthritis Over 20 Years: Results From the Norfolk Arthritis Register

M. Lunt, J. Humphreys, A. Warner, 2014, Arthritis care & research.

Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis

A. Silman, S. Hider, M. Lunt, 2006, Annals of the rheumatic diseases.

Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial

D. Symmons, A. Hassell, S. Verstappen, 2009, Annals of the rheumatic diseases.

Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis

Kenneth G. C. Smith, James C. Lee, P. Lyons, 2016, Arthritis & rheumatology.

Editorial: Do We Need a Disease‐Specific Cardiovascular Risk Calculator for Patients With Rheumatoid Arthritis?

D. Symmons, 2015, Arthritis & rheumatology.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

K. Hyrich, D. Symmons, K. Watson, 2009, Annals of the rheumatic diseases.

Investigation of C reactive protein gene polymorphisms as predictors of cardiovascular mortality in inflammatory polyarthritis: results from the Norfolk Arthritis Register

E. Flynn, M. Lunt, S. Verstappen, 2013, Annals of the rheumatic diseases.

In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register

D. Bunn, D. Symmons, M. Lunt, 2011, Annals of the rheumatic diseases.

Development and preliminary assessment of a simple measure of overall status in rheumatoid arthritis (OSRA) for routine clinical use.

D. Symmons, P. Jones, J. Schollum, 1995, QJM : monthly journal of the Association of Physicians.

The relationship between oral contraceptive use and functional outcome in women with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.

D. Symmons, T. Farragher, M. Lunt, 2011, Arthritis and rheumatism.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

K. Hyrich, D. Symmons, K. Watson, 2009, Annals of the rheumatic diseases.

Leg bone pain syndrome in a kidney transplant patient treated with tacrolimus (FK506)

J. Piette, Z. Amoura, D. Symmons, 1998, Annals of the rheumatic diseases.

Mirjafari, Hoda et al. (2014) N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results

I. Bruce, D. Symmons, N. Sattar, 2014 .

Rheumatoid arthritis in women: still associated with an increased mortality

N. Goodson, D. Symmons, N. Goodson, 2002, Annals of the rheumatic diseases.

Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity.

A. Silman, D. Symmons, E. Barrett, 2001, Arthritis and rheumatism.

Factors influencing mortality in rheumatoid arthritis.

D. Symmons, P. Prior, D. Scott, 1986, Journal of chronic diseases.

Self-reported pain severity is associated with a history of coronary heart disease

J. McBeth, D. Symmons, G. Macfarlane, 2014, European journal of pain.

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Francisco Bonachela Capdevila, J. Sergeant, A. Cuza, 2022, Scientific Data.

Health Assessment Questionnaire disability progression in early rheumatoid arthritis: Systematic review and analysis of two inception cohorts Seminars in Arthritis and Rheumatism

A. Wailoo, S. Norton, B. Fu, 2014 .

Health Assessment Questionnaire disability progression in early rheumatoid arthritis: Systematic review and analysis of two inception cohorts Seminars in Arthritis and Rheumatism

A. Wailoo, S. Norton, B. Fu, 2014 .